Erythropoiesis Stimulating Agents (ESAs)
J5 · Effective Oct 1, 2015
10 active Medicare policies list D75.821, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J15 · Effective Feb 10, 2020
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J5 · Effective Apr 1, 2025
National · Effective Mar 5, 2026
National · Effective Sep 24, 2026
3 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D75.821 |
|---|---|---|
| Coronary Artery Brachytherapy and Other Adjuncts to Coronary Interventions | Feb 16, 2024 | Covered |
| Plasmapheresis/Plasma Exchange/Therapeutic Apheresis | May 5, 2023 | Covered |
| Romiplostim (Nplate) | Jan 9, 2024 | Covered |
J5 · Effective Jan 1, 2026